Phase III Study of Vinflunine Plus Methotrexate Versus Methotrexate Alone in Patients With Head and Neck Cancer

Condition:   Recurrent or Metastatic Head and Neck Carcinoma
Interventions:   Drug: vinflunine;   Drug: Methotrexate
Sponsor:   Pierre Fabre Medicament
Recruiting - verified November 2016

http://ift.tt/2exrc9m